BPIQ Blog

Big/Suspected Movers FAQ/User Guide

What is a Big-Mover™ event? Big-Mover™ events are upcoming high-impact biopharma catalyst events, usually clinical trial read-outs, that...

Quarterly Big Mover Biotech Stocks To Watch

Our free Big-Mover Report : Listing of 10 of the biggest clinical readouts this quarter Use this info: To update your holdings before a...

Q2 2023 Product Revenue Analyses

We have gone through the Q2 2023 financial reports to analysis each companies product revenue to see: Q2 '23 revenue Q2 '22 revenue Q2...

BPIQ Q2 2023 Biotech Hedge Fund (13F) Analysis

Last updated 8/15/23 Summary: Hedge fund holdings can help you discover new investment ideas Get more stock idea and see the full list of...

SYFOVRE (APLS) vs. IZERVAY (Astellas)

Tough month for APLS • 1st: safety issue surfaces for SYFOVRE ⇨ Retinal Vasculitis • Now: IZERVAY approved early ⇨ Good for AMD patients...

BIIB & SAGE: Zuranolone

Big PDUFA from a big collaboration: BIIB & SAGE PDUFA - 8/5/23 - Zuranolone in MDD & PPD Collaboration since 2020… BIIB invested $1.5B in...

Apellis Pharmaceuticals (APLS)

BIOPHARMA STOCK NEWS FLASH APLS provides SYFOVRE safety update Background: SYFOVRE approved by FDA • Feb 2023 • pegcetacoplan injection •...

How to make $$$ investing in biopharma

Consistent with top 36 biopharma hedge funds • Each held 22-125 companies @ end Q1 ⇒ Stonepine (22 companies) ⇒ EcoR1 (58) ⇒ RA Capital...

Scpharmaceuticals (SCPH)... Is Summer Stock Dip a Buying Opportunity?

Overview: • Under the radar companies • Huge upside • Difficult FDA approval behind them ⇒ Typical for drug device combo ⇒ 2 CRLs • But...

PRTA & BMS Collaboration

PRTA tech validated by big BMS collaboration • BMS is part owner of PRTA BMS & PRTA collaboration highlights: 3/20/18 CELG & PRTA enter...

Jump start your biotech due diligence

Our platform helps you uncover your next biotech investment opportunity